Description
Tirzepatide is a 39-amino-acid synthetic peptide that binds both the GIP and GLP-1 receptors. It is modified with a fatty-acid side chain that extends its half-life in experimental systems.
Research context
Researchers use it as a reference dual agonist when comparing incretin receptor signalling, and in metabolic and receptor-pharmacology models. This product is a research reagent, not a pharmaceutical preparation.
Specifications
| Amount per vial | 10 mg or 20 mg (choose above) |
|---|---|
| Form | Lyophilized (freeze-dried) powder in a sealed glass vial |
| Storage | Store sealed vials at −20 °C, away from light. Once reconstituted, keep at 2–8 °C. |
| Intended use | In-vitro and laboratory research only |
For laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or supplement. Sold only to qualified researchers who accept our Research Use Policy.
Reviews
There are no reviews yet.